FDA Approved: SAXENDA — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approved a supplemental application for Saxenda (liraglutide) from Novo Nordisk, updating the product's labeling. The approval pertains to an expanded or mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SAXENDA (liraglutide)

Snippet

SUPPL AP for SAXENDA (LIRAGLUTIDE)